Toll-like receptor agonists as cancer vaccine adjuvants
Volume 20, Issue 1, December 2024 .
Source: Human Vaccines and Immunotherapeutics - Category: Allergy & Immunology Authors: Donghwan JeonEthan HillDouglas G. McNeela Department of Oncology, University of Wisconsin Carbone Cancer Center, Madison, WI, USAb Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, WI, USA Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Cancer Vaccines | University of Wisconsin | Vaccines